PubRank

Sara K Vesely

Author PubWeight™ 99.56‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med 2009 5.48
2 Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012 3.87
3 Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood 2009 3.18
4 Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood 2004 2.42
5 Clinical utility of D-dimer in patients with suspected pulmonary embolism and nondiagnostic lung scans or negative CT findings. Chest 2004 2.30
6 Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood 2008 2.17
7 Parental communication and youth sexual behaviour. J Adolesc 2006 1.87
8 Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports. Haematologica 2007 1.87
9 Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. Transfusion 2004 1.84
10 The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am J Hematol 2010 1.83
11 Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood 2010 1.76
12 Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. Eur J Haematol 2009 1.56
13 Drug-induced thrombocytopenia: an updated systematic review, 2008. Drug Saf 2009 1.52
14 Youth-parent communication and youth sexual behavior: implications for physicians. Fam Med 2006 1.50
15 Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood 2014 1.47
16 Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist 2007 1.45
17 The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. J Am Board Fam Pract 2004 1.34
18 Relationships among youth assets and neighborhood and community resources. Health Educ Behav 2005 1.28
19 Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion 2012 1.27
20 Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review. Transfusion 2007 1.19
21 Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer 2013 1.16
22 Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion 2006 1.14
23 Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood 2013 1.13
24 Reliability and validity of the youth asset survey (YAS). J Adolesc Health 2002 1.12
25 Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol 2011 1.10
26 The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS. Semin Hematol 2004 1.09
27 Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura. Transfusion 2009 1.09
28 Overlapping features of thrombotic thrombocytopenic purpura and systemic lupus erythematosus. South Med J 2007 1.00
29 Factor V Leiden: a genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor-cleaving protease activity. Blood 2002 1.00
30 Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica 2011 0.99
31 Adolescent tobacco use: the protective effects of developmental assets. Am J Health Promot 2002 0.96
32 Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders. J Clin Apher 2006 0.93
33 Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care. Am J Hematol 2003 0.93
34 Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol 2011 0.93
35 The association between multiple youth assets and sexual behavior. Am J Health Promot 2004 0.92
36 Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes. Am J Hematol 2010 0.92
37 Cognitive deficits after recovery from thrombotic thrombocytopenic purpura. Transfusion 2009 0.92
38 Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. Clin Infect Dis 2009 0.91
39 Complications of plasma exchange in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a study of 78 additional patients. Transfusion 2003 0.90
40 Protective assets for non-use of alcohol, tobacco and other drugs among urban American Indian youth in Oklahoma. Matern Child Health J 2008 0.90
41 Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency. Transfusion 2011 0.90
42 Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS). Blood 2013 0.90
43 Drug-induced thrombocytopenia in children. Pediatr Blood Cancer 2013 0.90
44 Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer. Presse Med 2012 0.88
45 Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol 2012 0.88
46 Referral of patients with thrombocytopenia from primary care clinicians to hematologists. Blood 2009 0.88
47 Drug-induced thrombocytopenia: an updated systematic review, 2006. Drug Saf 2007 0.88
48 The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: the Swiss connection. Eur J Haematol 2008 0.87
49 Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008. Transfusion 2009 0.86
50 First symptoms in patients with thrombotic thrombocytopenic purpura: what are they and when do they occur? Transfusion 2013 0.86
51 Conflicts of interest and clinical recommendations: comparison of two concurrent clinical practice guidelines for primary immune thrombocytopenia developed by different methods. Am J Med Qual 2013 0.86
52 Socioeconomic factors and health risk behaviors among adolescents. Am J Health Behav 2010 0.86
53 Youth assets, aggression, and delinquency within the context of family structure. Am J Health Behav 2005 0.85
54 School-related assets and youth risk behaviors: alcohol consumption and sexual activity. J Sch Health 2012 0.85
55 Methodological considerations in a community-based longitudinal study. Am J Health Behav 2008 0.85
56 A youth development approach to profiling sexual abstinence. Am J Health Behav 2003 0.85
57 Lessons learned from the Oklahoma thrombotic thrombocytopenic purpura-hemolytic uremic syndrome registry. J Clin Apher 2008 0.85
58 Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura. Transfusion 2008 0.84
59 Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison. Br J Haematol 2008 0.84
60 A longitudinal study of youth assets, neighborhood conditions, and youth sexual behaviors. J Adolesc Health 2013 0.83
61 Reliability and validity of the youth asset survey: an update. Am J Health Promot 2010 0.82
62 Plasma exchange complications in patients treated for thrombotic thrombocytopenia purpura-hemolytic uremic syndrome: 2011 to 2014. Transfusion 2014 0.82
63 Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin. Am J Hematol 2015 0.81
64 A support group for patients who have recovered from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): The six-year experience of the Oklahoma TTP-HUS Study Group. J Clin Apher 2003 0.81
65 Support groups for patients who have recovered from thrombotic thrombocytopenic purpura. J Clin Apher 2008 0.81
66 The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: a community service. J Okla State Med Assoc 2007 0.81
67 Determining a definite diagnosis of primary immune thrombocytopenia by medical record review. Am J Hematol 2012 0.81
68 Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006. Transfusion 2007 0.81
69 Quinine allergy causing acute severe systemic illness: report of 4 patients manifesting multiple hematologic, renal, and hepatic abnormalities. Proc (Bayl Univ Med Cent) 2003 0.80
70 Is immune thrombocytopenic purpura less common among black Americans? Blood 2005 0.80
71 Parental youth assets and sexual activity: differences by race/ethnicity. Am J Health Behav 2011 0.80
72 Youth assets and sexual abstinence in Native American youth. J Health Care Poor Underserved 2006 0.78
73 Accuracy of step recording in free-living adults. Res Q Exerc Sport 2007 0.78
74 Endemic Esherichia coil O157:H7 infections and hemolytic-uremic syndrome in Oklahoma, 2002-2005. J Okla State Med Assoc 2007 0.78
75 The predictive influence of family and neighborhood assets on fighting and weapon carrying from mid- to late adolescence. Prev Sci 2014 0.78
76 The impact of ruxolitinib on thrombosis in patients with polycythemia vera and myelofibrosis: a meta-analysis. Blood Coagul Fibrinolysis 2016 0.78
77 Determinants of salivary cotinine concentrations among smokeless tobacco users. Nicotine Tob Res 2011 0.78
78 Drug-induced thrombocytopenia: an updated systematic review. Ann Intern Med 2005 0.77
79 Prospective association between negative life events and initiation of sexual intercourse: the influence of family structure and family income. Am J Public Health 2015 0.77
80 Associations between youth assets and sexual intercourse by household income. Am J Health Promot 2011 0.77
81 How can we provide the best care for our patients with immune thrombocytopenic pupura? Mayo Clin Proc 2004 0.76
82 Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists. Am J Med Sci 2014 0.76
83 Immune thrombocytopenic purpura--let the treatment fit the patient. N Engl J Med 2003 0.76
84 Adjuvant chemotherapy for the "oldest old" ovarian cancer patients: can we anticipate toxicity-related treatment failure in a vulnerable population? Cancer 2009 0.76
85 A seasonal association of incident cases of thrombotic thrombocytopenic purpura was not observed in the Oklahoma TTP-HUS Registry. Transfusion 2012 0.75
86 Prospective Associations Among Assets and Successful Transition to Early Adulthood. Am J Public Health 2015 0.75
87 Addendum to corticosteroid side effects and risk for bleeding in immune thrombocytopenic purpura: patient perspectives. Eur J Haematol 2009 0.75
88 Thrombotic thrombocytopenic purpura: from the bench to the bedside, but not yet to the community. Ann Intern Med 2003 0.75
89 Reports of drug-induced thrombocytopenia. Ann Intern Med 2003 0.75
90 Inpatient versus outpatient management of neutropenic fever in gynecologic oncology patients: is risk stratification useful? Gynecol Oncol 2013 0.75
91 Correlates of thrombin generation in patients with advanced prostate cancer. Thromb Haemost 2003 0.75
92 Pulmonary involvement in patients with thrombotic thrombocytopenic purpura. Eur J Haematol 2013 0.75
93 Barriers And Motivators for Smoking Cessation in Patients With Systemic Lupus Erythematosus (SLE). J Okla State Med Assoc 2015 0.75
94 Tobacco cessation attitudes and behaviors among Oklahoma high school students. J Okla State Med Assoc 2002 0.75
95 Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets. Transfusion 2011 0.75